Edge Therapeutics' Series A - II Round

Edge Therapeutics raised a round of funding on June 24, 2011. Investors include The Enterprise Development Center.

Edge Therapeutics is a clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies capable of transforming treatment paradigms in the manag…

Articles about Edge Therapeutics' Series A - II Round: